Active Biotech
0,93 SEK -8,64 %Vær den første som følger denne virksomhed
Active Biotech develops drugs in disease areas such as cancer and inflammatory diseases where the immune system plays a crucial role. The company's project portfolio contains both small orally active immunomodulatory molecules and antibody-based immunotherapy. The company focuses on projects in specialist indications in disease areas such as hematological cancer, inflammatory eye diseases, and solid tumors.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
ACTI
Daglig lav / høj pris
0,9 / 1,018
SEK
Markedsværdi
246,34 mio. SEK
Aktieomsætning
149,49 t SEK
Volumen
157 t
Finanskalender
Delårsrapport
24.08.2023
Delårsrapport
09.11.2023
Årsrapport
08.02.2024
Viser Alle indholdstyper